Investigating the effect of magnesium on uterine contractions in woman with repeated implantation failure referred to infertility clinic

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230304057611N1

Enrollment

Registered

2023-11-04

Start date

2023-12-06

Completion date

Unknown

Last updated

2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility. Female infertility

Interventions

Intervention 1: Intervention group: One daily magnesium citrate tablet (300 mg, Sajpod company) for two months. Intervention 2: Control group: For the patients of the control group, a placebo pill sup

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Three unsuccessful IVF attempts ( negative BhCG ) Willingness to try next IVF Normal karyotype Normal level of LH, FSH, prolactin and TSH

Exclusion criteria

Exclusion criteria: Patient's refusal to continue treatment Any sensitivity or intolerance to magnesium Existence of systemic disease affecting infertility Presence of structural disease of the uterus

Design outcomes

Primary

Measure	Time frame
Magnesium level. Timepoint: before the intervention and at intervals of one month and two months later. Method of measurement: Lab Kit.	—

Secondary

Measure	Time frame
IVF result. Timepoint: After 14 days of doing IVF. Method of measurement: BHCG lab kit.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Maryam Eslami

Shahre-kord University of Medical Sciences

eslmaryam@yahoo.com+98 38 3322 5505

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026